US2010036115A1PendingUtilityA1

Novel Compositions for the Delivery of Negatively Charged Molecules

Assignee: SIRNA THERAPEUTICS INCPriority: Jul 23, 1997Filed: May 21, 2009Published: Feb 11, 2010
Est. expiryJul 23, 2017(expired)· nominal 20-yr term from priority
A61K 47/543A61K 38/05C07C 279/14C07H 19/06C07C 237/22C12N 15/88C07J 43/003C07D 213/64C07J 51/00C07C 279/12C07J 1/00A61K 47/54C07C 279/04C07J 41/0005C07C 237/06A61K 47/542
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention features permeability enhancer molecules, and methods, to increase membrane permeability of various molecules, such as nucleic acids, polynucleotides, oligonucleotides, enzymatic nucleic acid molecules, antisense nucleic acid molecules, 2-5A antisense chimeras, triplex forming oligonucleotides, decoy RNAs, dsRNAs, siRNAs, aptamers, or antisense nucleic acids containing nucleic acid cleaving chemical groups, peptides, polypeptides, proteins, carbohydrates, steroids, metals and small molecules, thereby facilitating cellular uptake of such molecules.

Claims

exact text as granted — not AI-modified
1 - 10 . (canceled) 
     
     
         11 . A cationic lipid having the formula VIII:
   R 8 -L 2 -Cholesterol   wherein, R 8  is selected from the group consisting of arginyl, N-Boc arginyl, homoarginyl, N-Boc homoarginyl, ornithine, N-Boc ornithine, N-benzyl histidyl, lysyl, N-Boc lysyl, N-methyl arginyl, N-methyl guanidine, guanidine and pyridoxyl: and   L 2  is a linker represented by NH, glycine, N-butyldiamine or guanidine.   
     
     
         12 . The cationic lipid of  claim 11 , wherein said cationic lipid is Boc arginine-cholesterylamide. 
     
     
         13 . The cationic lipid of  claim 11 , wherein said cationic lipid is N-cholesteryl-pyridoxamine. 
     
     
         14 . The cationic lipid of  claim 11 , wherein said cationic lipid is 3′,5′-Di-palmitoyl-2′-deoxy-2′-(N-carboxamidine-beta-alanineamido)uridine. 
     
     
         15 . The cationic lipid of  claim 11 , wherein said cationic lipid is linked to polyethylene glycol (PEG). 
     
     
         16 . The cationic lipid of  claim 15 , wherein said PEG is between about 2000-5000 daltons inclusive.

Join the waitlist — get patent alerts

Track US2010036115A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.